This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 10, 2014

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click here to view an article on the attempts to solve prescription drug abuse while protecting access for people with pain.

A new Biodesix study highlights VeriStrat’s ability to predict differential treatment outcomes between erlotinib and chemotherapy for non-small cell lung cancer.

Click here to read the press release!

Get up to date information on nutrition and nutrition research from Michael Greger, M.D. at NutritionFacts.org. Click here to view the website!

Granix is now available in the fight against neutropenia during chemotherapy. Click here to view the USPI! Visit www.granixrx.com for more information.

Click here to view the following free CME/CEU program:
Non-Invasive Pre Natal Testing: What Managed Care Needs to Know

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Click here to view the white paper.


 




GENOMICS

Same genes rule math, reading skills
AFP via Discovery News
A common set of genes play a role in learning to read and do math, with tiny variants influencing a child's skills in these tasks, according to a study published. But this ability is not just gene-driven, as schooling and help from parents are also vital contributors, its authors cautioned. Early numeracy and literacy are known to run in some families, but the genes that affect this have until now been mainly unknown.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




How genes can influence our mood
The Huffington Post
Michael Stanclift writes: When Susan first came to see me, she was feeling pretty low. She had debilitating fatigue, and her body ached all over. Susan had been prescribed an antidepressant, and it helped with her depression a little, but she was still constantly anxious and had difficulty concentrating. Everything seemed "life or death," her performance at work was declining, and she was afraid she would lose her job if things didn't change soon.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Healthy-obesity gene found — but genes aren't everything
TIME
Austrian researchers have discovered a possible genetic explanation for why about a quarter of obese people are “metabolically healthy” — meaning they don’t have the risk factors for Type 2 diabetes. In their mice study, published in the journal Cell, the researchers were able to determine that high levels of a molecule called HO-1 was linked to poor metabolic health and a higher risk for diabetes in people who are obese.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


ACCOUNTABLE CARE ORGANIZATIONS


Defining accountable care in the age of ACOs
Health Data Management
Physicians didn't wake up to a brave new world when Medicare unveiled its accountable care model and Pioneer ACO program — as medical doctors, the ultimate clinical decision makers in the healthcare industry, they were used to being personally and professionally accountable for their actions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACO initiatives test pharma's traditional sales model
Forbes
The U.S. healthcare system’s shift from volume- to value-based reimbursement for treatment in order to lower costs and improve patient care is disrupting healthcare business models. The high-profile government–led accountable care organizations, which put financial pressure on payers and providers to share responsibility for meeting quality and cost goals, is no exception.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


This startup will make you a personalized health plan based on your genes
Fast Company
When the FDA ordered 23andMe to stop giving customers medical information based on their DNA, they unintentionally opened a new market niche. The rapidly declining cost of genomic analysis means more and more companies can offer DNA analysis services for the consumer market. One new company, BaseHealth, is betting customers will like their proposition: A 23andMe-like platform where doctors have access to their patients' genomic data and build personalized medicine plans for their clients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CEUS: RN, CCM, Safety Training

Get CEUs and Safety Training for your Nurses and Case Managers! Group rates available! CareerSmart offers online CEUs and safety training applicable for Nurses, Case Managers and other healthcare professionals. They are designed to help staff prevent work-related injuries and maintain compliance with mandated continuing education requirements.
 


Francis Collins: Medicine in the future will be tailored to your genes
The Wall Street Journal
In 1889, when The Wall Street Journal was founded, medicine was quite primitive. An American born in that era could expect to live into his or her mid-40s on average, compared with nearly 80 today. There were no X-rays, aspirin, blood transfusions, insulin, oxygen equipment, antibiotics, childhood vaccines, heart surgeries, organ transplants, cholesterol-lowering drugs or many other medical breakthroughs we now take for granted.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Stem cell researchers under pressure to produce
The San Francisco Chronicle
In laboratories across California, scientists are racing to turn stem cells into therapies for some of the world's most debilitating illnesses from cancer to Alzheimer's. Many of those researchers have received funding from a unique source: California's stem cell agency. Created by voters a decade ago, the California Institute for Regenerative Medicine is authorized to spend $3 billion in taxpayer money on stem cell research and has so far doled out more than half of that in grants and loans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


Adipose stem cells: Potential option for female SUI
Medscape
Urethral injection of patient-derived adipose stem cells and collagen may represent a viable alternative to surgery in women with stress urinary incontinence, according to a pilot study published online in Stem Cells Translational Medicine. Although insertion of a suburethral sling remains the curative "gold standard" for female SUI, the procedure is not always effective.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Stem cell treatment causes nasal growth in woman's back
New Scientist
A woman in the U.S. has developed a tumor-like growth eight years after a stem cell treatment to cure her paralysis failed. There have been a handful of cases of stem cell treatments causing growths but this appears to be the first in which the treatment was given at a Western hospital as part of an approved clinical trial.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Contraceptive microchip: Could it revolutionize global birth control?
Medical News Today
MicroCHIPS, an IT start-up company with links to Massachusetts Institute of Technology, is developing a radical new contraceptive — a tiny microchip implanted under the skin that can be operated wirelessly by remote control. In the 1990s, Robert S. Langer — the David H. Koch Institute Professor at Massachusetts Institute of Technology and reportedly "the most cited engineer in history" — and his colleagues Michael Cima and John Santini, developed a microchip technology that could release controlled amounts of chemicals.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The rush to use new medical tech tied to patient harm
Modern Technology
Rapid adoption of new medical technology can lead to more adverse events for the patients treated with it, according to a new study. The authors advise hospitals to avoid using new devices without first considering the education, training and awareness needed to ensure safety.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Same genes rule math, reading skills
AFP via Discovery News
A common set of genes play a role in learning to read and do math, with tiny variants influencing a child's skills in these tasks, according to a study published.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Studies provide important new information on genetic risk of sudden cardiac death
Medical Xpress
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Older moms may have genes for longevity
The Washington Post
A silver lining for some older moms: The genes that allow some women to naturally have children later in life also make it likely these women will live a longer life.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MANAGED HEALTHCARE NEWS


Obamacare's next threat: A September surprise
POLITICO
Obamacare open enrollment closed March 31. The White House’s Obamacare war room did not. Most state health insurance rates for 2015 are scheduled to be approved by early fall, and most are likely to rise, timing that couldn’t be worse for Democrats already on defense in the midterms. The White House and its allies know they’ve been beaten in every previous round of Obamacare messaging, never more devastatingly than in 2010.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The frustrating lack of comparative effectiveness — Part I
By Mike Wokasch
When you go to the doctor's office, you expect your healthcare providers will prescribe drugs that will be effective and safe in treating your diagnosis. But which drug is best for treating your disease or medical condition? You rely on your physician or PA to make this determination. You also rely on your healthcare providers to have the treatment available on their formulary. And lastly, you rely on your insurance company to pay for your treatment of choice. You would expect them to make these determinations based on the best available clinical data and published medical literature. But what is the best available data?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Countries spending the most on healthcare
24/7 Wall St. via USA Today
The United States currently spends more per person on healthcare than any other developed country. Health outcomes in the U.S., however, are among the worst. Despite weak health spending growth worldwide, a number of countries still had substantial healthcare budgets as of 2012. Based on data released by the Organization for Economic Co-operation and Development, the U.S. led the developed world in 2012, spending $8,745 per capita on healthcare.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


Study: 99 percent of Alzheimer's drug trials fail
Drug Discovery & Development
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer’s disease, revealing an urgent need to increase the number of agents entering the drug development pipeline and progressing successfully towards new therapy treatments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA approves belinostat for rare lymphoma
Medscape
The U.S. Food and Drug Administration approved belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma, a rare and fast-growing type of non-Hodgkin's lymphoma. The endorsement of belinostat, which is an orphan drug, comes through the FDA's accelerated approval program and is based on overall response rate data.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Physicians lead most, best ACOs (HealthLeaders Media)
FDA struggles to regulate fecal transplants (The Associated Press via CBS News)
Profits in health insurance under Obamacare (Forbes)
Doctor group takes steps to fulfill the promise of telemedicine (Forbes)
Why your genes aren't a language (Forbes)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
July 3, 2014
June 26, 2014
June 19, 2014
June 12, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063